1
|
Burnett C, Bestall JC, Burke S, Morgan E, Murray RL, Greenwood-Wilson S, Williams GF, Franks KN. Prehabilitation and Rehabilitation for Patients with Lung Cancer: A Review of Where we are Today. Clin Oncol (R Coll Radiol) 2022; 34:724-732. [PMID: 36088168 DOI: 10.1016/j.clon.2022.08.028] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2022] [Revised: 07/15/2022] [Accepted: 08/15/2022] [Indexed: 01/31/2023]
Abstract
Lung cancer is the third most common type of cancer in the UK, with nearly 50 000 new cases diagnosed a year. Treatments for lung cancer have improved in recent years with the advent of new surgical and radiotherapy techniques and the increased use of immunotherapies. These advances have resulted in increasing numbers of patients surviving beyond the completion of their treatment. Lung cancer patients are now not dying from their cancer diagnosis, but from other co-existing pathologies. Lung cancer patients commonly present with multiple comorbidities. Mitigating the effects of poor lifestyles and changing behaviours may improve the efficacy of treatments, reduce side-effects and improve the quality of life for lung cancer patients. Published evidence supports the use of interventions to manage behavioural habits, to optimise the health of patients. There is no consensus as to what, when or how to embed these into the patient pathway. Supporting patients before, during and after their cancer treatments to increase activity, eat well and stop smoking have been seen to decrease side-effects and improve patient outcomes and wellbeing. The challenge is to provide a package of interventions that is acceptable to patients and fits within the patient pathway so as not to conflict with diagnostic and therapeutic activities. This article reviews where we are today with providing behavioural support to optimise the health of lung cancer patients undergoing treatment.
Collapse
Affiliation(s)
- C Burnett
- Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK; Leeds Institute of Medical Research at St James's Hospital, University of Leeds, Leeds, UK.
| | - J C Bestall
- Leeds Institute of Health Sciences, University of Leeds, Leeds, UK
| | - S Burke
- School of Biomedical Sciences, University of Leeds, Leeds, UK
| | - E Morgan
- Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK; Leeds Institute of Medical Research at St James's Hospital, University of Leeds, Leeds, UK
| | - R L Murray
- Academic Unit of Lifespan and Population Health, School of Medicine, University of Nottingham, Nottingham, UK
| | - S Greenwood-Wilson
- Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK; Leeds Institute of Medical Research at St James's Hospital, University of Leeds, Leeds, UK
| | - G F Williams
- Department of Nutrition and Dietetics, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| | - K N Franks
- Faculty of Medicine and Health, University of Leeds, Leeds, UK
| |
Collapse
|
2
|
Liu ZJ, Zhang YL, Huang YG. Prehabilitation in video-assisted thoracoscopic surgery lobectomy for lung cancer: current situation and future perspectives. J Thorac Dis 2020; 12:4578-4580. [PMID: 32944379 PMCID: PMC7475593 DOI: 10.21037/jtd-20-1930] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Affiliation(s)
- Zi-Jia Liu
- Department of Anesthesiology, Peking Union Medical College Hospital, Beijing, China
| | - Yue-Lun Zhang
- Medical Research Center, Peking Union Medical College Hospital, Beijing, China
| | - Yu-Guang Huang
- Department of Anesthesiology, Peking Union Medical College Hospital, Beijing, China
| |
Collapse
|